The mechanisms for the three cancers that this study supports are, for breast cancer, a decrease in sex-hormone-binding globulin and hormonal factors; for colorectal cancer, steroid hormones and chronic inflammation; and for renal cell carcinoma, an increased level of estrogen. This evidence concerns the gene SHBG and renal cell carcinoma.